AU5416394A - Cisplatinum/oxaliplatinum combination - Google Patents

Cisplatinum/oxaliplatinum combination

Info

Publication number
AU5416394A
AU5416394A AU54163/94A AU5416394A AU5416394A AU 5416394 A AU5416394 A AU 5416394A AU 54163/94 A AU54163/94 A AU 54163/94A AU 5416394 A AU5416394 A AU 5416394A AU 5416394 A AU5416394 A AU 5416394A
Authority
AU
Australia
Prior art keywords
oxaliplatinum
cisplatinum
combination
oxaliplatinum combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54163/94A
Inventor
Houssam Ibrahim
Teruko Irie
Rolland-Yves Mauvernay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm SA filed Critical Debiopharm SA
Publication of AU5416394A publication Critical patent/AU5416394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU54163/94A 1992-11-24 1993-11-24 Cisplatinum/oxaliplatinum combination Abandoned AU5416394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH3592/92 1992-11-24
CH359292 1992-11-24
PCT/CH1993/000266 WO1994012193A1 (en) 1992-11-24 1993-11-24 Cisplatinum/oxaliplatinum combination

Publications (1)

Publication Number Publication Date
AU5416394A true AU5416394A (en) 1994-06-22

Family

ID=4259316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54163/94A Abandoned AU5416394A (en) 1992-11-24 1993-11-24 Cisplatinum/oxaliplatinum combination

Country Status (2)

Country Link
AU (1) AU5416394A (en)
WO (1) WO1994012193A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2152412T3 (en) * 1994-08-08 2001-02-01 Debiopharm Sa PHARMACEUTICALLY STABLE PREPARATION OF OXALIPLATINO.
ES2206478T3 (en) * 1994-11-11 2004-05-16 Debiopharm S.A. CARCINOSTATIC COMPOSITIONS CONTAINING CIS-OXALIPLATIN AND OTHER OR OTHER COMPATIBLE CARCINOSTATIC SUBSTANCES.
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
KR100688217B1 (en) * 1999-08-30 2007-02-28 데비오 팜 소시에떼 아노님 pharmaceutically stable oxaliplatinum preparation for parenteral administation
US20040126431A1 (en) * 2000-10-03 2004-07-01 Frederic Lagarce Method for preparing microspheres containing a water-soluble substance
WO2002047725A2 (en) 2000-12-12 2002-06-20 Debiopharm S.A. Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
DE10113185A1 (en) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Composition containing a gallium (III) complex and a therapeutically active platinum complex
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
WO2004046214A2 (en) 2002-10-15 2004-06-03 Exxonmobil Chemical Patents Inc. Multiple catalyst system for olefin polymerization and polymers produced therefrom
CZ300795B6 (en) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Pharmaceutical composition and process for its preparation
WO2009087660A1 (en) * 2007-11-12 2009-07-16 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
CN104523674B (en) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 A kind of composition for injection using oxaliplatin as main ingredient composition

Also Published As

Publication number Publication date
WO1994012193A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
AU4166393A (en) Auto-reclosers
AU6672794A (en) Antineoplastic heteronaphthoquinones
AU7961094A (en) Picosulphate dosage form
AU3561193A (en) TNF-muteins
AU3780393A (en) Quinobenzoxazine, quinobenzothiazine, and pyrido-acridine antineoplastic agents
AU3991693A (en) Pyrazinoindoles
AU4488393A (en) Antacid
AU4177593A (en) Benzophenonehydrazones
AU5416394A (en) Cisplatinum/oxaliplatinum combination
AU4334493A (en) Intubation devices
AU3042892A (en) Rockbolt
AU4156393A (en) Heterocyclyltriazolinones
AU2843992A (en) Plasterboard reveal
AU4348493A (en) Inhaler
EP0567918A3 (en) Azopigment preparation
AU664253B2 (en) Photo-deviometer
AU5063493A (en) Fitting
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU5737494A (en) Human thrombospondin-4
AU4164793A (en) Heterocyclyltriazolinones
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU4632493A (en) Weathershed
AU5414094A (en) Antineoplastic heteronaphthoquinones
AU3185693A (en) Pyrrolylbenzodiazepinones